Free Trial

BioLineRx (BLRX) News Today

BioLineRx logo
$3.65 -0.03 (-0.82%)
Closing price 08/28/2025 03:59 PM Eastern
Extended Trading
$3.66 +0.00 (+0.14%)
As of 07:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLRX Latest News

Research Analysts Issue Forecasts for BioLineRx Q3 Earnings
BLRX: ASCO Poster & Abstract
BioLineRx Ltd. (BLRX) Q2 2025 Earnings Call Transcript
15 Best Growth Stocks to Invest in for the Next 5 Years
Double Upgrade Issued stock metrics - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.
3 Stocks Getting Rare Double Upgrades From Analysts (BLRX)
These three stocks have received a rare double upgrade from analysts since their most recent earnings reports; fortunately investors still have time to catch up...
BioLineRx upgraded to Buy from Hold at JonesResearch
BLRX: 2024 Financial Results
BioLineRx downgraded to Hold from Buy at JonesResearch
BioLineRx Ltd. (BLRX) Q4 2024 Earnings Call Transcript
BLRX: Aphexda Transition Progressing
BioLineRx trading halted, news pending
BioLineRx says current cash to provide runway through 2H26
BioLineRx Issues Letter to Shareholders
BioLineRx changes ratio of ADRs to ordinary shares
BioLineRx announces $10M registered direct offering
BLRX: Ayrmid Assumes Commercialization Efforts
Get BioLineRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLRX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BLRX Media Mentions By Week

BLRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLRX
News Sentiment

0.94

1.03

Average
Medical
News Sentiment

BLRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLRX Articles
This Week

2

1

BLRX Articles
Average Week

Get the Latest News and Ratings for BLRX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for BioLineRx and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:BLRX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners